重新审视胎儿透明隔腔宽或窄的意义
本研究基于2020年12月至2022年1月孕16+0至36+6周的横断面研究,用低危妊娠构建透明隔腔(CSP)宽度参考范围,将高于第95百分位定义为宽、低于第5百分位定义为窄;在神经超声正常胎儿中,产前孤立性CSP宽或窄似乎不增加新生儿神经发育延迟风险。
要点
- 产前孤立性透明隔腔宽或窄似乎不增加新生儿神经发育延迟风险。
- 宽CSP定义为CSP宽度高于第95百分位,窄CSP定义为低于第5百分位。
- 神经超声组中宽CSP占9.7%、窄CSP占7.6%,其SWYC低于阈值比例与一般人群相似。
核心结论
- 产前孤立性透明隔腔宽或窄似乎不增加新生儿神经发育延迟的风险。
研究设计与样本
- 横断面研究,纳入2020年12月至2022年1月孕16+0至36+6周的胎儿,共352例;其中138例健康且新生儿结局无并发症的胎儿构成对照组并用于构建CSP宽度参考范围;185例神经超声组胎儿中,宽CSP占9.7%、窄CSP占7.6%。
诊断标准与关键数值
- CSP宽度参考范围由低危妊娠构建;宽CSP定义为CSP宽度高于第95百分位,窄CSP定义为低于第5百分位;神经超声组中宽CSP胎儿33.3%、窄CSP胎儿22.2%的SWYC评分低于预期发育里程碑阈值,该比例与一般人群相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate short-term neonatal developmental outcomes in fetuses with an isolated wide or narrow cavum septi pellucidi (CSP) using new reference ranges.
METHODS: A cross-sectional study on fetuses at 16 + 0 to 36 + 6 weeks of gestation between December 2020 and January 2022. CSP width reference ranges were constructed from low-risk pregnancies. Wide and narrow CSPs were defined as measurements above the 95th percentile and below the 5th percentile, respectively. For the primary outcome fetuses with normal neurosonograms were included. Neonatal developmental outcomes were assessed using the Survey of Well-being of Young Children (SWYC).
RESULTS: A total of 352 fetuses were included in this study, of whom 138 were healthy and had uncomplicated neonatal outcomes. These fetuses constituted the control group and were used to construct the CSP width reference ranges. Of 185 fetuses in the neurosonography group, 9.7% had wide and 7.6% had narrow CSPs, of whom 33.3% and 22.2%, respectively, scored below the SWYC threshold for expected developmental milestones, a rate similar to that reported in the general population.
CONCLUSIONS: The presence of a prenatally isolated wide or narrow CSP does not appear to increase the risk of neonatal neurodevelopmental delay.
引用
- Sichitiu J, Ghannad-Zadeh K, Van Mieghem T, et al. Revisiting the Implications of a Wide or Narrow Fetal Cavum Septi Pellucidi. J Ultrasound Med. 2024. PMID: 38708946. doi:10.1002/jum.16470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。